Detalhe da pesquisa
1.
Triple blockade of Ido-1, PD-L1 and MEK as a potential therapeutic strategy in NSCLC.
J Transl Med
; 20(1): 541, 2022 11 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-36419183
2.
A wake-up call for cancer DNA damage: the role of Schlafen 11 (SLFN11) across multiple cancers.
Br J Cancer
; 125(10): 1333-1340, 2021 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-34294893
3.
Giving AXL the axe: targeting AXL in human malignancy.
Br J Cancer
; 116(4): 415-423, 2017 Feb 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-28072762
4.
Small cell lung cancer: where do we go from here?
Cancer
; 121(5): 664-72, 2015 Mar 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-25336398
5.
Comprehensive analysis of transcription factor-based molecular subtypes and their correlation to clinical outcomes in small-cell lung cancer.
EBioMedicine
; 102: 105062, 2024 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-38492534
6.
BRAF v600E-mutant cancers treated with vemurafenib alone or in combination with everolimus, sorafenib, or crizotinib or with paclitaxel and carboplatin (VEM-PLUS) study.
NPJ Precis Oncol
; 7(1): 19, 2023 Feb 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-36801912
7.
Neoadjuvant chemotherapy plus nivolumab with or without ipilimumab in operable non-small cell lung cancer: the phase 2 platform NEOSTAR trial.
Nat Med
; 29(3): 593-604, 2023 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-36928818
8.
A Phase II Trial of Prexasertib (LY2606368) in Patients With Extensive-Stage Small-Cell Lung Cancer.
Clin Lung Cancer
; 22(6): 531-540, 2021 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-34034991
9.
A Reversible Shift of Driver Dependence from EGFR to Notch1 in Non-Small Cell Lung Cancer as a Cause of Resistance to Tyrosine Kinase Inhibitors.
Cancers (Basel)
; 13(9)2021 Apr 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-33922104
10.
Veliparib in Combination with Carboplatin and Etoposide in Patients with Treatment-Naïve Extensive-Stage Small Cell Lung Cancer: A Phase 2 Randomized Study.
Clin Cancer Res
; 27(14): 3884-3895, 2021 07 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-33947690
11.
Veliparib in Combination With Platinum-Based Chemotherapy for First-Line Treatment of Advanced Squamous Cell Lung Cancer: A Randomized, Multicenter Phase III Study.
J Clin Oncol
; 39(32): 3633-3644, 2021 11 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-34436928
12.
Patterns of transcription factor programs and immune pathway activation define four major subtypes of SCLC with distinct therapeutic vulnerabilities.
Cancer Cell
; 39(3): 346-360.e7, 2021 03 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-33482121
13.
Lung Cancer Models Reveal Severe Acute Respiratory Syndrome Coronavirus 2-Induced Epithelial-to-Mesenchymal Transition Contributes to Coronavirus Disease 2019 Pathophysiology.
J Thorac Oncol
; 16(11): 1821-1839, 2021 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-34274504
14.
Lung cancer models reveal SARS-CoV-2-induced EMT contributes to COVID-19 pathophysiology.
bioRxiv
; 2021 Jan 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-32577652
15.
Resolving the Spatial and Cellular Architecture of Lung Adenocarcinoma by Multiregion Single-Cell Sequencing.
Cancer Discov
; 11(10): 2506-2523, 2021 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-33972311
16.
Neoadjuvant nivolumab or nivolumab plus ipilimumab in operable non-small cell lung cancer: the phase 2 randomized NEOSTAR trial.
Nat Med
; 27(3): 504-514, 2021 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-33603241
17.
Combined vascular endothelial growth factor receptor and epidermal growth factor receptor (EGFR) blockade inhibits tumor growth in xenograft models of EGFR inhibitor resistance.
Clin Cancer Res
; 15(10): 3484-94, 2009 May 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-19447865
18.
This Is Our Cells Under Pressure: Decreased DNA Damage Repair in Response to Targeted Therapies Facilitates the Emergence of Drug-Resistant Clones.
Cancer Cell
; 37(1): 5-7, 2020 01 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-31951562
19.
The MEK5-ERK5 Kinase Axis Controls Lipid Metabolism in Small-Cell Lung Cancer.
Cancer Res
; 80(6): 1293-1303, 2020 03 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-31969375
20.
Single-cell analyses reveal increased intratumoral heterogeneity after the onset of therapy resistance in small-cell lung cancer.
Nat Cancer
; 1: 423-436, 2020 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-33521652